Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-138330
Filing Date
2021-11-12
Accepted
2021-11-12 20:18:05
Documents
2
Period of Report
2021-11-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2132597-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2132597-5_4seq1.xml 4 8653
2 EXHIBIT 24 tm2132597d5_ex24.htm EX-24 6945
  Complete submission text file 0001104659-21-138330.txt   16973
Mailing Address C/O ALEXZA PHARMACEUTICALS, INC. 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
Lippe Robert A (Reporting) CIK: 0001600757 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39724 | Film No.: 211405747

Mailing Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709
Business Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709 919.328.4400
Liquidia Corp (Issuer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations